6,507 reports of this reaction
10.1% of all LACOSAMIDE reports
#1 most reported adverse reaction
SEIZURE is the #1 most commonly reported adverse reaction for LACOSAMIDE, manufactured by UCB, Inc.. There are 6,507 FDA adverse event reports linking LACOSAMIDE to SEIZURE. This represents approximately 10.1% of all 64,711 adverse event reports for this drug.
Patients taking LACOSAMIDE who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a frequently reported adverse event for LACOSAMIDE, accounting for a significant proportion of all reports.
In addition to seizure, the following adverse reactions have been reported for LACOSAMIDE:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 6,507 FDA reports for LACOSAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 10.1% of all adverse event reports for LACOSAMIDE, making it one of the most commonly reported side effect.
If you experience seizure while taking LACOSAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.